Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis

Table 3

Association between serum NOS2, nNO, and clinical variables in AR patients.

Variable	Serum NOS2 level		nNO
		value		value
Age	-0.239	0.020	-0.137	0.189
BMI	-0.121	0.246	-0.214	0.039
Disease duration	0.140	0.180	-0.003	0.980
Baseline VAS	0.025	0.809	-0.003	0.980
Baseline TNSS	0.025	0.808	0.029	0.794
nNO	0.480	<0.001	—	—
Serum NOS2 level	—	—	0.480	<0.001

BMI: body mass index; nNO: nasal nitric oxide; TNSS: total nasal symptom score; VAS: visual analogue scale.